📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Waning of mRNA Boosters after Homologous Primary Series with BNT162b2 or ChadOx1 Against Symptomatic Infection and Severe COVID-19 in Brazil and Scotland: A Test-Negative Design Case-Control Study (2022)

First Author: Cerqueira-Silva T

Attributed to: Early Assessment of COVID-19 epidemiology and Vaccine/anti-viral Effectiveness (EAVE II) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2139/ssrn.4082927

Publication URI: http://dx.doi.org/10.2139/ssrn.4082927

Type: Journal Article/Review

Parent Publication: SSRN Electronic Journal